RxDoctor Payments DataLook up a doctor →

Deborah Peck, PA

Medical · Grand Blanc, MINPI 1548282098

Payments from drug & device makers

$13,851in general payments, 2019–2025

Across 678 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$1K
  • Johnson & Johnson$901
  • Novartis$813
  • Merck$680
  • AstraZeneca$674
  • Eisai Inc.$500
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,37597%
  • Education$4763%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.61$1,203
Johnson & Johnson40$901
Novartis45$813
Merck36$680
AstraZeneca(2 entities)33$674
Eisai Inc.25$500
Daiichi Sankyo Inc.24$447
Amgen23$437
E.r. Squibb & Sons, L.L.C.22$386
AVEO Pharmaceuticals, Inc.15$383
Gilead(2 entities)16$382
Lilly USA, LLC16$346
EMD Serono, Inc.15$308
AbbVie13$297
Takeda Pharmaceuticals U.S.A., Inc.12$294
Sanofi14$291
Tersera Therapeutics LLC13$283
Beigene USA, Inc.11$243
Pharmaessentia USA Corporation10$237
Bayer11$232
Seagen Inc.12$223
Incyte Corporation11$221
Ipsen Biopharmaceuticals, Inc11$221
Bristol Myers Squibb12$215
Mirati Therapeutics, Inc.15$214
Servier Pharmaceuticals LLC10$205
Pfizer11$189
GSK7$161
Regeneron Healthcare Solutions, Inc.6$158
Pharmacyclics LLC, An Abbvie Company8$158
Astellas Pharma US Inc7$156
Exelixis Inc.8$152
Jazz Pharmaceuticals Inc.6$146
Sobi, Inc6$142
Rigel Pharmaceuticals, Inc.8$139
Genmab U.S., Inc.6$138
Array Biopharma Inc7$123
Stemline Therapeutics Inc.5$98
G1 Therapeutics, Inc.5$82
Geron Corporation2$79
Deciphera Pharmaceuticals Inc.4$76
Pharmacosmos Therapeutics Inc.4$76
Syndax Pharmaceuticals, Inc.3$70
Adaptive Biotechnologies Corporation3$68
Caris MPI, Inc.2$68
Blueprint Medicines Corporation3$67
Taiho Oncology, Inc.3$63
Karyopharm Therapeutics Inc.3$57
Kyowa Kirin, Inc.3$55
Iovance Biotherapeutics, Inc.2$53
Recordati_rare_diseases_inc.2$51
Acrotech Biopharma Inc.2$50
Agios Pharmaceuticals, Inc.2$48
Octapharma USA, Inc.2$47
Alnylam Pharmaceuticals Inc.2$39
Nuvation Bio Inc.1$34
Legend Biotech USA Inc.1$29
Emmaus Medical, Inc.2$29
ADC Therapeutics America, Inc.1$29
Myriad Genetic Laboratories, Inc.1$28

How this compares

$13,851 in reported general payments places this provider in the 95th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$2,589
Medicare patients
23
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl22$471
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$376
Morphine Sulfate ErMorphine Sulfate12$340

Paid to pharmacies, not to this prescriber.

Other medical in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →